Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
NeuroVasx
AddedFeb 15, 2024
UpdatedJun 18, 2026
NeuroVasx

NeuroVasx

Public

NeuroVasx, a medical device company, develops and markets minimally-invasive stroke treatments and cerebrovascular disorder solutions globally.

HQ
Maple Grove, MN, US
Founded
1997
Overview
Compare
Fundraising
Employees

NeuroVasx is a medical device company engaged in the development and commercialization of technologies for the minimally-invasive treatment of hemorrhagic and ischemic strokes in the United States and internationally.

The company offers cPAX, a polymer strand delivered through a micro catheter for the minimally-invasive treatment of hemorrhagic and ischemic strokes as well as for the embolization of cerebral and intracranial aneurysms, abnormal bulges, and sacs in the wall of an artery in the brain. Its products are used to treat acute stroke and other cerebrovascular disorders. NeuroVasx was founded in 1997 and is based in Maple Grove, Minnesota, United States.

NeuroVasx - Similar Companies

NeuroVasc Technologies logo

NeuroVasc Technologies

CereVasc logo

CereVasc

cerevasc.com

Mivi Neuroscience logo

Mivi Neuroscience

mivineuro.com

NeuRx Medical logo

NeuRx Medical

neurxmed.com

Vaso logo

Vaso

Neurvana Medical logo

Neurvana Medical

Rist Neurovascular logo

Rist Neurovascular

ristneuro.com

Nervive logo

Nervive

Nanovasc logo

Nanovasc

nanovasc.com

Pulsar Vascular logo

Pulsar Vascular

Cvrx logo

Cvrx

cvrx.com

Progressive Nuero logo

Progressive Nuero

Scientia Vascular logo

Scientia Vascular

NeuroSave logo

NeuroSave

TheraVasc logo

TheraVasc

NeuroVasx - Quick Facts

Who are NeuroVasx's competitors?

Companies similar to NeuroVasx include NeuroVasc Technologies, CereVasc, Mivi Neuroscience and NeuRx Medical.

When was NeuroVasx founded?

NeuroVasx was founded in 1997.

Where is NeuroVasx's headquarters located?

NeuroVasx's headquarters is located in Maple Grove, MN, US.

How much has NeuroVasx raised to-date?

As of Oct 2, 2018, NeuroVasx has raised a total of $8.5M (USD).

How many employees does NeuroVasx have?

NeuroVasx has 6 employees as of Feb 5, 2024.

NeuroVasx - Classification

Industry
  • Hardware
Ownership
  • Public
Technology
  • Analytics
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
  • Government
Main Product
  • Medical Devices
Tags
  • Healthtech
  • Medical
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified